Stay updated on Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 replaces the previous Revision: v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.4.2 and the old government funding status notice and Revision: v3.4.1 have been removed, which are administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center operating status was added. Revision: v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedGlossary is now displayed on the page, improving terminology clarity. QC-related labels have been updated and the release notes show Revision: v3.4.0, with minor wording changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive changes to the study details are evident.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was updated to reflect participating sites with a new revision (v3.3.3); older location entries (v3.3.2) have been removed.SummaryDifference2%

Stay in the know with updates to Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.